[HTML][HTML] Systematic review for the medical applications of meditation in randomized controlled trials

DY Kim, SH Hong, SH Jang, SH Park, JH Noh… - International journal of …, 2022 - mdpi.com
Background: Meditation has been increasingly adapted for healthy populations and
participants with diseases. Its beneficial effects are still challenging to determine due to the …

[HTML][HTML] Psychological interventions for people with Huntington's disease: a call to arms

N Zarotti, M Dale, F Eccles… - Journal of Huntington's …, 2020 - content.iospress.com
Background: Although Huntington's disease (HD) can cause a wide range of psychological
difficulties, no review has ever been carried out on the range of psychological interventions …

[HTML][HTML] Guideline “motor neuron diseases” of the German Society of Neurology (deutsche Gesellschaft für Neurologie)

S Petri, T Grehl, J Grosskreutz, M Hecht… - … Research and Practice, 2023 - Springer
Abstract Introduction In 2021, the Deutsche Gesellschaft für Neurology published a new
guideline on diagnosis and therapy of motor neuron disorders. Motor neuron disorders affect …

Caregiver experience, health‐related quality of life and life satisfaction among informal caregivers to patients with amyotrophic lateral sclerosis: A cross‐sectional …

P Sandstedt, S Littorin, G Cröde Widsell… - Journal of clinical …, 2018 - Wiley Online Library
Aims and objectives This study set out to describe caregiver experience, health‐related
quality of life and life satisfaction among informal caregivers to patients with amyotrophic …

An online non-meditative mindfulness intervention for people with ALS and their caregivers: a randomized controlled trial

F Pagnini, D Phillips, A Haulman… - … Lateral Sclerosis and …, 2022 - Taylor & Francis
Objectives: Mindfulness-based interventions seem to be effective in promoting QOL of ALS
patients and caregivers, but most require substantial time. In the Langerian approach …

Stress and neurodegeneration

C Peña-Bautista, E Casas-Fernández, M Vento… - Clinica Chimica …, 2020 - Elsevier
Neurodegenerative diseases are a great concern because of aging worldwide population.
Despite substantial effort to advance our understanding of the etiology and potential …

Pathophysiology and treatment of non-motor dysfunction in amyotrophic lateral sclerosis

CJ Mahoney, RM Ahmed, W Huynh, S Tu, JD Rohrer… - CNS drugs, 2021 - Springer
Amyotrophic lateral sclerosis is a progressive and fatal neurodegenerative disease typically
presenting with bulbar or limb weakness. There is increasing evidence that amyotrophic …

[HTML][HTML] Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel …

RL Gould, CJ McDermott, BJ Thompson, CV Rawlinson… - The Lancet, 2024 - thelancet.com
Background Motor neuron disease is a progressive, fatal neurodegenerative disease for
which there is no cure. Acceptance and Commitment Therapy (ACT) is a psychological …

Experiences of mindfulness-based cognitive therapy for premanifest Huntington's disease

FJR Eccles, D Craufurd, A Smith… - Journal of …, 2021 - content.iospress.com
Background: Psychological difficulties such as anxiety, depression, and irritability are
common in Huntington's disease, even for premanifest individuals. However, very little …

Mutual support groups for family caregivers of people with amyotrophic lateral sclerosis in Italy: A pilot study

S Cipolletta, GR Gammino… - Health & social care …, 2018 - Wiley Online Library
Family caregivers of people with amyotrophic lateral sclerosis (ALS) live stressful lives in
which they spend most of their time caring for their loved ones and managing difficult …